Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Piazza

Showing results (201-210 of 204) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 204 results.
Hemasphere|January 25, 2020
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, et al.
British Journal of Haematology|November 9, 2018
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for deathCarlo Visco, Maria C Tisi, Andrea Evangelista, et al.
The Lancet. Haematology|September 20, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 studyCarlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Pageof 21

Showing results (201-210 of 204) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 204 results.
Hemasphere|January 25, 2020
MYC Rearranged Aggressive B-Cell Lymphomas: A Report on 100 Patients of the Fondazione Italiana Linfomi (FIL)Maria Chiara Tisi, Simone Ferrero, Irene Dogliotti, et al.
British Journal of Haematology|November 9, 2018
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for deathCarlo Visco, Maria C Tisi, Andrea Evangelista, et al.
The Lancet. Haematology|September 20, 2025
Rituximab, bendamustine, and cytarabine followed by venetoclax in older patients with high-risk mantle cell lymphoma (FIL_V-RBAC): a multicentre, single-arm, phase 2 studyCarlo Visco, Valentina Tabanelli, Maria Vittoria Sacchi, et al.
Blood|October 15, 2021
Genetic and phenotypic attributes of splenic marginal zone lymphomaFerdinando Bonfiglio, Alessio Bruscaggin, Francesca Guidetti, et al.
Pageof 21